| Financial Year |
March 31 2023 |
| Monetary Funds |
55,528,662.86 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
38,620,655.59 |
| Accounts Receivable |
320,739,052.47 |
| Advances to Suppliers |
14,087,670.25 |
| Other Receivables |
24,324,669.72 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
122,526,498.86 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
16,510,648.56 |
| Total Current Assets |
633,109,138.06 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
119,999,100.64 |
| Investment Properties |
178,718,367.08 |
| Fixed Assetes |
175,297,148.22 |
| Under-construction Projects |
11,344,705.56 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
27,605,044.07 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
20,016,809.13 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
550,761,035.50 |
| Total Assets |
1,183,870,173.56 |
| Short-Term Loans |
121,400,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
27,037,965.20 |
| Accounts Payable |
129,246,240.29 |
| Accounts Received In Advance |
351,076.16 |
| Employee Compensation Payable |
11,545,278.29 |
| Taxes Payable |
8,649,421.80 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
26,277,774.96 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,675,058.92 |
| Other Current Liabilities |
23,184,625.09 |
| Sub-Total of Current Liabilities |
378,733,036.65 |
| Long-term Loans |
15,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
15,553,020.00 |
| Total Liabilities |
394,286,056.65 |
| Paid-In Capital(Or Share Stock) |
188,170,355.00 |
| Capital Surplus |
407,989,901.27 |
| Surplus Reserve |
50,619,497.75 |
| LESS:Treasury Stock |
8,003,616.90 |
| Undistributed Profits |
150,429,354.86 |
| Minority Stockholder's Interest |
378,624.93 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
789,205,491.98 |
| Owner's Equity（Stockholder's Equity） |
789,584,116.91 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,183,870,173.56 |
